Disease | hyperandrogenism |
Phenotype | C0032460|polycystic ovaries |
Sentences | 3 |
PubMedID- 21577021 | Presence of oligo- and/or anovulation (anov) and hyperandrogenemia and/or hyperandrogenism (ha) with or without polycystic ovaries (pco)) appear to have a more adverse metabolic profile than patients diagnosed with the additional criteria introduced in 2003 (i.e. |
PubMedID- 23226657 | This possibly indicates that hyperinsulinemia is the primary factor involved in polycystic ovaries in patients with lipodystrophy, hyperandrogenism, and its peripheral manifestations ensue secondarily. |
PubMedID- 21521255 | All probands had pcos, defined by symptoms of anovulation and/or hyperandrogenism with polycystic ovaries on ultrasound. |
Page: 1